SANGAMO THERAPEUTICS, INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sangamo Therapeutics, Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Sangamo Therapeutics, Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $10.6M.
  • Sangamo Therapeutics, Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$140M, a 47.6% increase year-over-year.
  • Sangamo Therapeutics, Inc annual Operating Income (Loss) for 2023 was -$274M, a 36.1% decline from 2022.
  • Sangamo Therapeutics, Inc annual Operating Income (Loss) for 2022 was -$201M, a 9.79% decline from 2021.
  • Sangamo Therapeutics, Inc annual Operating Income (Loss) for 2021 was -$183M, a 41.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$140M $10.6M +$117M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$257M -$37.1M +$86.5M +70% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$344M -$51.5M -$69.6M -386% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$274M -$62.1M -$6.67M -12% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 -$267M -$106M -$51.5M -93.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$216M -$124M -$77.8M -170% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$138M $18M +$63.3M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$201M -$55.4M -$15.5M -38.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$186M -$54.9M -$6.46M -13.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 -$179M -$45.7M +$2.97M +6.09% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$182M -$45.3M +$1.04M +2.25% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$183M -$39.9M +$3.53M +8.14% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 -$187M -$48.4M -$44.7M -1209% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$142M -$48.7M -$10.8M -28.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$131M -$46.3M -$1.78M -4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$130M -$43.4M -$44.9M -3057% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 -$84.7M -$3.7M +$25.5M +87.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$110M -$37.9M -$4.39M -13.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$106M -$44.5M -$625K -1.42% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$105M $1.47M +$22.2M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$127M -$29.2M -$13M -80.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$114M -$33.5M -$14.4M -75% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$100M -$43.9M -$22.9M -109% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$77.2M -$20.8M -$7.01M -50.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 -$70.1M -$16.2M -$3.21M -24.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$66.9M -$19.1M -$6.37M -49.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$60.6M -$21M -$4.21M -25% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$56.4M -$13.8M -$3.94M -40% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 -$52.4M -$13M +$6.17M +32.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$58.6M -$12.8M +$14.1M +52.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$72.7M -$16.8M -$111K -0.67% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$72.6M -$9.83M +$5.84M +37.3% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 -$78.4M -$19.2M -$6.52M -51.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$71.9M -$26.8M -$14.6M -119% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$57.3M -$16.7M -$10.5M -168% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$46.9M -$15.7M -$11.2M -251% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 -$35.7M -$12.7M -$5.03M -65.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 -$30.6M -$12.3M -$5.23M -74.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$25.4M -$6.22M +$1.39M +18.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$26.8M -$4.47M +$3.71M +45.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 -$30.5M -$7.65M -$1.5M -24.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-30
Q2 2014 -$29M -$7.05M -$1.58M -28.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$27.4M -$7.61M -$706K -10.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q4 2013 -$26.7M -$8.17M -$4.81M -143% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-18
Q3 2013 -$21.9M -$6.16M -$357K -6.15% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 -$21.5M -$5.47M +$276K +4.81% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-29
Q1 2013 -$21.8M -$6.91M +$378K +5.19% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 -$22.2M -$3.37M +$3M +47.1% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 -$25.2M -$5.8M +$3.77M +39.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-04
Q2 2012 -$29M -$5.74M +$4.54M +44.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 -$33.5M -$7.28M +$2.32M +24.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$35.8M -$6.37M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-24
Q3 2011 -$9.57M -$859K -9.86% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 -$10.3M -$6.4M -165% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 -$9.6M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-07
Q3 2010 -$8.72M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 -$3.88M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.